Saglit is a tablet from Synovia Pharma PLC., with the generic name Pioglitazone. It can be used on its own, or combined with other diabetes medicines such as a sulphonylurea, metformin or insulin, when diet, exercise and a single medicine do not give adequate control.
There are 12 brands of Pioglitazone listed in Bangladesh. 7 of them have a lower unit price than Saglit. The lowest listed price is Pioglinet 15 mg Tablet at ৳ 1 per unit.
What is Saglit 15 mg Tablet?
Saglit is a tablet from Synovia Pharma PLC., with the generic name Pioglitazone. Its generic name is Pioglitazone, which belongs to the thiazolidinedione group of oral antidiabetic medicines. It helps lower insulin resistance in the body and improves how the body handles glucose. The doctor decides whether it suits a particular person.
Uses of Saglit
It can be used on its own, or combined with other diabetes medicines such as a sulphonylurea, metformin or insulin, when diet, exercise and a single medicine do not give adequate control. It may be prescribed on its own or in combination with a sulphonylurea, metformin or insulin when a single agent plus diet and exercise does not give adequate control. Saglit 15 mg tablet is used to improve blood sugar control in adults with type II diabetes, together with diet and exercise. Your doctor will decide if it is appropriate for your situation.
How to use Saglit
Keep following your diet and exercise plan while using it. Swallow the tablet with water. Saglit is taken by mouth. Swallow the tablet as advised. Complete the course exactly as prescribed. Ask your doctor or pharmacist if you are unsure how to take it, and tell them about any other medicines you use.
Side effects of Saglit
In placebo-controlled trials of Pioglitazone, the more commonly reported events included upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and sore throat. Some people may notice side effects such as upper respiratory tract infection, headache, sinusitis, muscle pain, tooth problems or sore throat. Seek medical help if a symptom is severe or does not settle. Contact your doctor if you notice anything unusual after taking it. Your doctor will advise on monitoring and follow-up.
Safety and precautions
It is not known whether it passes into human milk, and it should not be given to a breastfeeding woman. Saglit 15 mg tablet works only when insulin is present, so it should not be used in type I diabetes or diabetic ketoacidosis. Tell your doctor about pregnancy, breastfeeding, liver problems or allergies before starting it.
Frequently asked questions
What is Saglit used for?
It can be used on its own, or combined with other diabetes medicines such as a sulphonylurea, metformin or insulin, when diet, exercise and a single medicine do not give adequate control. It may be prescribed on its own or in combination with a sulphonylurea, metformin or insulin when a single agent plus diet and exercise does not give adequate control.
How should I take Saglit?
Keep following your diet and exercise plan while using it. Swallow the tablet with water.
What should I watch for while using Saglit?
In placebo-controlled trials of Pioglitazone, the more commonly reported events included upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and sore throat. Some people may notice side effects such as upper respiratory tract infection, headache, sinusitis, muscle pain, tooth problems or sore throat.
Pioglitazone is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Pioglitazone is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
Pharmacology
Pioglitazone is a preparation of Pioglitazone which is a member of the newest class of oral antidiabetic agent called thiazolidinediones. It depends on the presence of Insulin for its mechanism of action. Pioglitazone decreases Insulin resistance in the periphery and in the liver, resulting in increased Insulin dependent glucose disposal and decreased hepatic glucose output. It also improves abnormality in lipid metabolism by activating peroxisome proliferator activated receptor gamma (PPAR-γ).
Dosage & Administration
Pioglitazone can be taken once daily without regard to meals. The management of antidiabetic therapy should be individualized. Pioglitazone monotherapy may be initiated at 15 mg or 30 mg once daily dosages in patients not adequately controlled with diet and exercise alone. For patients who respond inadequately to the initial dose of Pioglitazone, the dose can be increased up to 45 mg once daily. For patients not responding adequately to monotherapy, combination therapy should be considered.
Maximum recommended daily dose of Pioglitazone should not exceed 45 mg since doses higher than 45 mg have not been studied in placebo controlled clinical studies. Besides, no placebo controlled clinical studies of more than 30 mg once daily have been conducted in combination therapy.
Interaction
Administration of thiazolidinediones with an oral contraceptive containing ethinyl oestradiol and norethindrone reduces the plasma concentration of both hormones by approximately 30% which could result in loss of contraception.
Contraindications
Pioglitazone is contraindicated in patients with known hypersensitivity to any of its components.
Side Effects
The overall incidence and types of adverse events reported in placebo controlled clinical trials of Pioglitazone monotherapy at doses of 7.5 mg, 15 mg, 30 mg or 45 mg once daily are upper respiratory tract infection (13.2%), headache (9.1%), sinusitis (6.3%), myalgia (5.4%), tooth disorder (5.3%), and pharyngitis (5.1%).
Pregnancy & Lactation
Pregnancy: There are no adequate and well controlled studies in pregnant women. Pioglitazone should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Lactation: It is not known whether Pioglitazone is secreted in human milk. As many drugs are excreted in human milk, it should not be administered to a lactating women.
Precautions & Warnings
Pioglitazone exerts its antihyperglycaemic effect only in the presence of Insulin. Therefore, it should not be used in Type 1 diabetes or for the treatment of diabetic ketoacidosis. Pioglitazone should be used with caution in case of combination antidiabetic therapy and hepatic insufficiency. Liver enzyme should be monitored regularly.
Alternative brands of Pioglitazone
Other brands with the same generic name, cheapest first.